Analyst Ratings For LifePoint Health (NASDAQ:LPNT)
Today, LifePoint Health (NASDAQ:LPNT) stock received an upgrade by Raymond James Financial from Market Perform to Outperform.
Some recent analyst ratings include
- 3/15/2018-Raymond James Financial Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 3/5/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ” rating to a ” Market Perform” rating. They now have a $58.00 price target on the stock, up previously from $46.30 .
- 2/26/2018-Credit Suisse Group Reiterated Rating of Neutral .
- 2/26/2018-Morgan Stanley Reiterated Rating of Equal Weight .
- On 2/28/2018 William F Carpenter III, Chairman, bought 21,368 with an average share price of $46.80 per share and the total transaction amounting to $1,000,022.40.
- On 1/16/2018 David M Dill, Insider, sold 45,000 with an average share price of $48.52 per share and the total transaction amounting to $2,183,400.00.
- On 11/28/2017 Marguerite Kondracke, Director, sold 3,907 with an average share price of $44.73 per share and the total transaction amounting to $174,760.11.
- On 11/21/2017 Marguerite Kondracke, Director, sold 3,416 with an average share price of $43.80 per share and the total transaction amounting to $149,620.80.
- On 7/17/2017 William F Carpenter III, Chairman, sold 17,653 with an average share price of $65.06 per share and the total transaction amounting to $1,148,504.18.
- On 6/15/2017 William F Carpenter III, Chairman, sold 82,347 with an average share price of $64.15 per share and the total transaction amounting to $5,282,560.05.
- On 5/11/2017 Richard H Evans, Director, sold 2,000 with an average share price of $62.88 per share and the total transaction amounting to $125,760.00.
Recent Trading Activity for LifePoint Health (NASDAQ:LPNT)
Shares of LifePoint Health closed the previous trading session at with shares trading hands.